| 2024-03-18 | Sale | Tarsus Pharmaceuticals, Inc. TARS | General Counsel | 4,436 0.0118% | $30.60 | $135,742 | +11.67% | |
| 2023-11-30 | Sale | Tarsus Pharmaceuticals, Inc. TARS | General Counsel | 8,356 0.025% | $16.31 | $136,286 | +91.86% | |
| 2023-03-23 | Sale | Tarsus Pharmaceuticals, Inc. TARS | General Counsel | 371 0.0014% | $12.15 | $4,508 | +43% | |
| 2023-03-22 | Sale | Tarsus Pharmaceuticals, Inc. TARS | General Counsel | 357 0.0014% | $12.64 | $4,512 | +44.1% | |
| 2023-03-21 | Sale | Tarsus Pharmaceuticals, Inc. TARS | General Counsel | 350 0.0013% | $12.89 | $4,512 | +34.34% | |
| 2023-03-20 | Sale | Tarsus Pharmaceuticals, Inc. TARS | General Counsel | 357 0.0013% | $12.61 | $4,502 | +32.72% | |
| 2023-03-17 | Sale | Tarsus Pharmaceuticals, Inc. TARS | General Counsel | 339 0.0013% | $13.28 | $4,502 | +35.53% | |
| 2023-03-16 | Sale | Tarsus Pharmaceuticals, Inc. TARS | General Counsel | 337 0.0013% | $13.43 | $4,526 | +28.69% | |
| 2022-12-02 | Sale | Tarsus Pharmaceuticals, Inc. TARS | General Counsel | 1,154 0.0046% | $16.90 | $19,503 | -8.34% | |
| 2022-12-01 | Sale | Tarsus Pharmaceuticals, Inc. TARS | General Counsel | 1,164 0.0047% | $16.75 | $19,497 | -5.68% | |
| 2022-11-30 | Sale | Tarsus Pharmaceuticals, Inc. TARS | General Counsel | 1,183 0.0047% | $16.50 | $19,520 | -5% |